ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 300 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $549 | +13.7% | 33,832 | +29.1% | 0.00% | 0.0% |
| Q1 2024 | $483 | +82.3% | 26,213 | +208.6% | 0.00% | – |
| Q4 2023 | $265 | +100.8% | 8,494 | +33.5% | 0.00% | – |
| Q3 2023 | $132 | +34.7% | 6,361 | +54.2% | 0.00% | – |
| Q2 2023 | $98 | +71.9% | 4,125 | +35.8% | 0.00% | – |
| Q1 2023 | $57 | -99.9% | 3,037 | -17.7% | 0.00% | – |
| Q3 2022 | $60,000 | -16.7% | 3,689 | +18.4% | 0.00% | – |
| Q4 2021 | $72,000 | +67.4% | 3,115 | +19.4% | 0.00% | – |
| Q3 2021 | $43,000 | -40.3% | 2,609 | +92.4% | 0.00% | – |
| Q4 2020 | $72,000 | +30.9% | 1,356 | 0.0% | 0.00% | – |
| Q3 2020 | $55,000 | -67.8% | 1,356 | -66.6% | 0.00% | – |
| Q1 2020 | $171,000 | -93.5% | 4,060 | -93.4% | 0.00% | -100.0% |
| Q4 2019 | $2,645,000 | +9020.7% | 61,846 | +7488.5% | 0.00% | – |
| Q3 2019 | $29,000 | – | 815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
| GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
| Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
| Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
| Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
| Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
| Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
| PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |